These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7525023)

  • 1. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain.
    Yasuhara O; Aimi Y; McGeer EG; McGeer PL
    Brain Res; 1994 Aug; 652(2):346-9. PubMed ID: 7525023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of clusterin in Alzheimer brain tissue.
    McGeer PL; Kawamata T; Walker DG
    Brain Res; 1992 May; 579(2):337-41. PubMed ID: 1378350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.
    Conti F; Grude P; Calmus Y; Scoazec JY
    J Hepatol; 1997 Nov; 27(5):881-9. PubMed ID: 9382976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of complement in the aetiology of Pick's disease?
    Singhrao SK; Neal JW; Gasque P; Morgan BP; Newman GR
    J Neuropathol Exp Neurol; 1996 May; 55(5):578-93. PubMed ID: 8627348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.
    French LE; Tschopp J; Schifferli JA
    Clin Exp Immunol; 1992 Jun; 88(3):389-93. PubMed ID: 1606720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforant path transection induces complement C9 deposition in hippocampus.
    Johnson Sa; Young-Chan CS; Laping NJ; Finch CE
    Exp Neurol; 1996 Apr; 138(2):198-205. PubMed ID: 8620918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
    Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
    APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
    Hakulinen J; Meri S
    Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).
    Rautemaa R; Meri S
    J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
    Väkevä A; Laurila P; Meri S
    Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.
    Tandon N; Yan SL; Morgan BP; Weetman AP
    Immunology; 1994 Apr; 81(4):643-7. PubMed ID: 7518800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of complement regulatory proteins by adult human oligodendrocytes.
    Scolding NJ; Morgan BP; Compston DA
    J Neuroimmunol; 1998 Apr; 84(1):69-75. PubMed ID: 9600710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.
    Høgåsen K; Mollnes TE; Brandtzaeg P
    Infect Immun; 1994 Nov; 62(11):4874-80. PubMed ID: 7523299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).
    Chauhan AK; Moore TL
    Clin Exp Immunol; 2006 Sep; 145(3):398-406. PubMed ID: 16907906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of the sixth complement component and, spatial and temporal expression profile of MAC structural and regulatory genes in chicken.
    Mikrou A; Zarkadis IK
    Dev Comp Immunol; 2010 May; 34(5):485-90. PubMed ID: 20067805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supported Lipid Bilayer Platform To Test Inhibitors of the Membrane Attack Complex: Insights into Biomacromolecular Assembly and Regulation.
    Yorulmaz S; Jackman JA; Hunziker W; Cho NJ
    Biomacromolecules; 2015 Nov; 16(11):3594-602. PubMed ID: 26444518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin.
    French LE; Polla LL; Tschopp J; Schifferli JA
    J Invest Dermatol; 1992 May; 98(5):758-63. PubMed ID: 1569324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration.
    Johnson LV; Leitner WP; Staples MK; Anderson DH
    Exp Eye Res; 2001 Dec; 73(6):887-96. PubMed ID: 11846519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.